$KNTK

ISQ Global Fund II GP LLC (Wahba Sadek, Bhandari Gautam) sold $3.4M of KNTK (indirect holdings)

ISQ Global Fund II GP LLC sold 64,131 indirectly-held shares of Kinetik Holdings Inc. (KNTK) at an average of $53.66 ($53.55–$53.72, $3.44M total) across 2 trades over 2026-09-22 to 2026-09-23. Filed jointly with I Squared Capital, LLC (10% owner), ISQ Holdings, LLC (10% owner), Wahba Sadek (10% owner) and Bhandari Gautam (10% owner).

Original reporting
SEC EDGAR · ISQ Global Fund II GP LLC, I Squared Capital, LLC, ISQ Holdings, LLC, Wahba Sadek, Bhandari Gautam
Published Sep 24, 2026, 9:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 24, 2026, 9:51 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$KNTK
Bearish
medium confidence
Mentioned
$KNTK
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KNTKBearishLow
01

Why it matters

The disclosed sale reduces the insider's stake but the holder remains a significant shareholder. Market reaction may be limited unless accompanied by further insider activity.

02

Market read

Primary relevance is to traders monitoring insider activity for KNTK; broader market impact is negligible.

03

What to watch

No 10b5‑1 plan was in place, suggesting the sale was discretionary and could be a one‑off event.

Relevance 6/10Novelty 5/10Timing: filing date 2026-09-24

Background

Kinetik Holdings Inc. (KNTK) is a micro‑cap listed on NASDAQ. Insider transactions are required to be reported on Form 4.

Company-level read

Ticker impact

$KNTKBearishMedium confidence
Context

Form 4 disclosed ISQ Global Fund II GP LLC sold 64,131 shares of KNTK for $3.44M, reducing its stake to 384,142 shares.

Expected impact

Possible modest downside pressure over the next few days.

Evidence & confidence

The sale size is notable for a micro‑cap, but the insider remains a 10% owner, limiting the impact.

Market effects

Minimal; reflects typical insider activity in the biotech/health‑tech sector.

None; the filing is company‑specific.

Low; does not affect broader market trends.

Counterpoint

The insider may be liquidating for unrelated cash needs; the sale does not imply negative fundamentals.

Key entities

  • Kinetik Holdings Inc.

    Issuer of the securities sold.

  • ISQ Global Fund II GP LLC

    Reporting entity and 10% owner of KNTK.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$KNTKMedAI 8/10

Why is Kinetik Holdings stock surging today?

Kinetik Holdings' stock rose 5.2% in after-hours trading after Bloomberg reported the company is exploring strategic alternatives, including a potential sale. The company posted record Q2 2026 results with revenue up 36% YoY and net income more than doubled. Kinetik's management had raised its full-year 2026 guidance. U.S. equities broadly sold off during regular trading hours, with the S&P 500, Dow Jones, and Nasdaq all declining.

Med

Kinetik stock jumps 5% on potential sale exploration report

Kinetik Holdings Inc. (KNT) shares rose 5% in after-hours trading after reports it is exploring strategic options, including a potential sale. The company, backed by Blackstone Inc. (BX), has a market value of $8.9B. No final decision has been made. Kinetik closed regular trading at $54.55, down 0.8% but up 30% over the past year.